Alterome Therapeutics Stock
HealthTechLooking to sell Alterome Therapeutics stock or options?
Alterome Therapeutics specializes in precision oncology treatments aimed at targeting oncogenic drivers. The company's approach leverages structure-guided drug discovery and sophisticated computational chemistry to create alteration-specific small molecule therapies. This enables the healthcare industry to address cancer targets with novel, selective treatments that enhance patient outcomes and increase survival rates.
Investors Include:
Goldman Sachs Asset Management, Blue Owl Capital, Invus Opportunities, Canaan Partners, Boxer Capital, Vida Ventures (Boston), The Goldman Sachs Group, Colt Ventures, Digitalis Ventures, OrbiMed.